Filing Details

Accession Number:
0001209191-15-018813
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-02-25 20:00:35
Reporting Period:
2015-02-23
Filing Date:
2015-02-25
Accepted Time:
2015-02-25 20:00:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1463729 Receptos Inc. RCPT Pharmaceutical Preparations (2834) 264190792
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552293 Edward S. Torres C/O Receptos, Inc.
3033 Science Park Road, Suite 300
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-02-23 26,400 $129.95 892,761 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Lilly Ventures Fund I, LLC (the "Fund").
  2. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.51 to $133.14 per share, inclusive. The reporting person undertakes to provide to Receptos, Inc., any security holder of Receptos, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. These shares are owned directly by Lilly Ventures Fund I, LLC (the "Fund"). Eli Lilly and Company, as sole Managing Member of the Fund, and pursuant to provisions of the LLC Agreement of the Fund, has voting authority with respect to shares owned by the Fund. S. Edward Torres is a non-managing member of the Fund and may be deemed to beneficially own the shares. Mr. Torres disclaims beneficial ownership of the shares held of record by the Fund, except to the extent of his pecuniary interest therein.